12
Oct 2026
Aquatic environments are recognized as reservoirs and pathways for antimicrobial resistance, receiving antibiotic residues and resistant microorganisms from sewage, livestock farming, and aquaculture.
12
Oct 2026
Rabies virus detection in cell cultures could soon become faster and more accessible, thanks to a world-first AI system developed by researchers at the University of Surrey's Institute for People-Centred AI (PAI) in collaboration with the Rabies and Viral Zoonoses team at the Animal and Plant Health Agency (APHA).
12
Oct 2026
In an analysis of data on adolescents and young adults with breast cancer, lower income and younger age were linked with delays in care.
%2c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg "Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukemia")
12
Oct 2026
Amphista Therapeutics Limited ('Amphista'), a leader in the discovery and development of non-cereblon / VHL targeted protein degradation (TPD) medicines, today announced dosing of the first patient in a Phase 1 trial for its lead candidate, AMX-883. Initiated following authorization from the U.S. Food and Drug Administration in June 2026, the BRAMLIE trial will investigate the safety, pharmacokinetics, and preliminary efficacy of AMX-883 monotherapy in participants with AML and high-risk MDS.
12
Oct 2026
Pediatricians urge against raw milk, highlighting its link to foodborne illnesses and advocating for pasteurized alternatives to safeguard children's health.
12
Oct 2026
Weaker handgrip strength correlates with severe long COVID symptoms, highlighting its potential as a measure for muscle dysfunction and recovery challenges.
12
Oct 2026
Findings from a nationwide study suggest HPV vaccination may reduce adverse pregnancy outcomes, emphasizing its importance in reproductive health strategies.
12
Oct 2026
A study of more than 25,000 analytical group assignments involving high-risk adults with type 2 diabetes found that sustained real-time continuous glucose monitoring (rtCGM) was associated with substantial improvements in blood sugar control over three years. Continued use was also linked to lower levels of a marker of kidney damage after three years, although researchers found no evidence that the technology preserved kidney filtration function.
12
Oct 2026
In a randomized trial of 106 adolescents and young adults with hereditary cancer predisposition, adding AYA-RISE to a clinic visit improved knowledge of cancer risk before age 30 compared with a clinic visit alone. Researchers observed no increase in distress, but the main analyses did not establish additional benefits for lifetime-risk or screening knowledge.
12
Oct 2026
Researchers developed EpiScreen, an AI system that distinguished epilepsy from psychogenic non-epileptic seizures using clinical notes from 13,633 patient records across two institutions. AI assistance improved neurologists’ classification accuracy in a retrospective assessment of 300 cases, but prospective studies must establish its performance and benefits in routine clinical care.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
